Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
Si-Si ChenKai LiJie WuZi-Yang PengZhi-Dong WangJi-Chang WangChong-Wen XuCai-Lin ZhuBao-Cheng LiHong RenShou-Ching TangXin SunPublished in: Journal of cancer research and clinical oncology (2020)
The detection regarding stem signatures associated antibodies could be used as effective tools in early NSCLC diagnosis, but not for localized screening of cancers, and their abnormal expression was in accordance with poorer survival.